US-Corp-1800028 V2
News
- Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyApril 20, 2021 - 4:05 pm
- Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsMarch 16, 2021 - 4:05 pm
- Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:40 am
Events
- Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
- Event: Kindred Biosciences to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:45 am
- Event: Kindred Biosciences to Present at the Barclays Global Healthcare ConferenceMarch 2, 2021 - 8:43 am
$4.71
0.06 (1.29%)

|